Delivery Order SPE2DR25D3103-SPE2DR26F9J64
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $13,460.59 to AmerisourceBergen Drug Corp for DELSTRIGO (100-300-300 mg tablets), a fixed-price pharmaceutical delivery with an ultimate completion date of November 14, 2025. This competitively awarded, non-set-aside order represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a...
- The Defense Logistics Agency awarded a delivery order valued at $44,900.61 to AmerisourceBergen Drug Corp on May 21, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in quantities of 30 count units. This firm fixed-price delivery order, with an ultimate completion date of May 22, 2025, represents a competitive award with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a $5,253.34 delivery order to AmerisourceBergen Drug Corp on May 20, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit quantity. The contract utilizes firm fixed price pricing with no set-aside designation and is scheduled for completion by May 21, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a small-value...
- The Defense Logistics Agency awarded a delivery order valued at $7,086.70 to AmerisourceBergen Drug Corp for Delstrigo 100-300-300 mg tablets (30-count units). This firm fixed-price delivery order, with an ultimate completion date of December 24, 2025, represents a non-competitive, non-set-aside procurement issued on December 23, 2025. The award is executed under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $1 billion global...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a specialty pharmaceutical product. The contract has a completion date of January 29, 2024 and a potential value of $17,807.95. This delivery order is part of a larger indefinite delivery contract (IDC) awarded to Amerisourcebergen Drug Corp by DLA, which has a potential value of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Delstrigo (100-300-300 mg tablets) in a 30-count unit package. This competitively awarded, non-set-aside delivery order has a ceiling value of $10,080.18 and a firm fixed price structure, with an ultimate completion date of May 9, 2025. The place of performance is listed as the vendor's corporate office location in Conshohocken, Pennsylvania. Delstrigo is an antiretroviral...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,944,624 units of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. The contract has a firm fixed price of $37,530.36 and a period of performance through April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
- The U.S. government agency's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract, valued at $8,655.98, is for the delivery of the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S. This contract does not have a set-aside designation. The award is part of a larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,398.12 firm fixed-price delivery order is for the supply of DELSTRIGO 100-300-300 MG TAB UU 30S, a pharmaceutical product. The contract has an ultimate completion date of November 26, 2024. This contract award is associated with a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA...
- This is a delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The order is for the pharmaceutical product DELSTRIGO 100-300-300 MG TAB UU 30S, with a firm fixed price of $4,766.08 and a completion date of January 5, 2024. The contract has no set-aside designation. Amerisourcebergen Drug Corp, as a prime contractor, has previously received numerous federal contract awards from DLA...
- SPE2DR25D3103Indefinite Delivery Contract
- SPE2DR25D3103-SPE2DR26F9J64Delivery Order
The Defense Logistics Agency awarded a delivery order valued at $43,857.85 to AmerisourceBergen Drug Corp for DELSTRIGO 100-300-300 mg tablets (30-count units) with a firm fixed price structure. The contract was competitively awarded without any set-aside designation and is scheduled for completion by November 26, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform all work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's substantial Indefinite Delivery Contract with DLA Troop Support Medical (designated SPE2DX), valued at $999,999,999.00 through December 2026. This prime contract vehicle provides comprehensive global pharmaceutical support to military healthcare programs and enables the company to supply a diverse range of medications, vaccines, and medical supplies across multiple therapeutic domains to the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. The DELSTRIGO delivery order represents a routine pharmaceutical procurement supporting ongoing military medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $43.9k | 11/24/25 |